CEACAM5 and colorectal carcinoma: As a means of evaluating the role that cfDNA plays in CRC screening, our research compared the specificity and sensitivity of cfDNA and three other tumor biomarkers (CEA, CA125, and VEGF), followed by ROC curve analysis.